These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34938086)

  • 1. Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant
    Zhu Y; Xiao T; Wang Y; Yang K; Zhou Y; Luo Q; Shen P; Xiao Y
    Infect Drug Resist; 2021; 14():5385-5393. PubMed ID: 34938086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China.
    Yang K; Xiao T; Shi Q; Zhu Y; Ye J; Zhou Y; Xiao Y
    J Glob Antimicrob Resist; 2021 Sep; 26():101-107. PubMed ID: 34023532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD; Shorr AF
    J Hosp Med; 2013 Oct; 8(10):559-63. PubMed ID: 24022878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study.
    Stewardson AJ; Marimuthu K; Sengupta S; Allignol A; El-Bouseary M; Carvalho MJ; Hassan B; Delgado-Ramirez MA; Arora A; Bagga R; Owusu-Ofori AK; Ovosi JO; Aliyu S; Saad H; Kanj SS; Khanal B; Bhattarai B; Saha SK; Uddin J; Barman P; Sharma L; El-Banna T; Zahra R; Saleemi MA; Kaur A; Iregbu K; Uwaezuoke NS; Abi Hanna P; Feghali R; Correa AL; Munera MI; Le TAT; Tran TTN; Phukan C; Phukan C; Valderrama-Beltrán SL; Alvarez-Moreno C; Walsh TR; Harbarth S
    Lancet Infect Dis; 2019 Jun; 19(6):601-610. PubMed ID: 31047852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.
    Cao W; Zhang J; Bian Z; Li L; Zhang S; Qin Y; Wan D; Jiang Z; Zhang R
    Infect Drug Resist; 2022; 15():5993-6006. PubMed ID: 36262593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
    Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream Infections in Patients with Rectal Colonization by Carbapenem-Resistant Enterobacteriaceae: A Prospective Cohort Study.
    Chu W; Hang X; Li X; Ye N; Tang W; Zhang Y; Yang X; Yang M; Wang Y; Liu Z; Zhou Q
    Infect Drug Resist; 2022; 15():6051-6063. PubMed ID: 36277248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem-Resistant
    Madney Y; Aboubakr S; Khedr R; Hafez H; Ahmed N; Elsheshtawy K; Elanany M; Salahelden A; Shalaby L; Galal Behairy O
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital.
    Li C; Li Y; Zhao Z; Liu Q; Li B
    J Infect Public Health; 2019; 12(1):26-31. PubMed ID: 30145151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae.
    Huang W; Qiao F; Zhang Y; Huang J; Deng Y; Li J; Zong Z
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S225-S230. PubMed ID: 30423052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
    Nabarro LEB; Shankar C; Pragasam AK; Mathew G; Jeyaseelan V; Veeraraghavan B; Verghese VP
    Pediatr Infect Dis J; 2017 Jun; 36(6):e161-e166. PubMed ID: 28005691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics, risk factors, and outcomes of patients hospitalized in the US military health system with carbapenem-resistant Enterobacteriaceae infection.
    Adams DJ; Susi A; Nylund CM
    Am J Infect Control; 2020 Jun; 48(6):644-649. PubMed ID: 31757476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections.
    Lu L; Xu C; Tang Y; Wang L; Cheng Q; Chen X; Zhang J; Li Y; Xiao H; Li X
    Infect Drug Resist; 2022; 15():2901-2914. PubMed ID: 35693849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multi-Centered Case-Case-Control Study of Factors Associated With Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae Infections in Children and Young Adults.
    Logan LK; Nguyen DC; Scaggs Huang FA; Qureshi NK; Charnot-Katsikas A; Bartlett AH; Zheng X; Hujer AM; Domitrovic TN; Marshall SH; Bonomo RA; Weinstein RA
    Pediatr Infect Dis J; 2019 May; 38(5):490-495. PubMed ID: 30169484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
    Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
    BMC Infect Dis; 2017 Apr; 17(1):279. PubMed ID: 28415969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
    Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic, clinical, and outcome characteristics of carbapenem-resistant Enterobacteriaceae over a 10-year period (2010-2020) in Oman.
    Khamis F; Al-Zakwani I; Molai M; Mohsin J; Al Dowaiki S; Al Bahrani M; Petersen E
    IJID Reg; 2022 Sep; 4():165-170. PubMed ID: 36059919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
    Giannella M; Trecarichi EM; Giacobbe DR; De Rosa FG; Bassetti M; Bartoloni A; Bartoletti M; Losito AR; Del Bono V; Corcione S; Tedeschi S; Raffaelli F; Saffioti C; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viscoli C; Lewis RE; Viale P; Tumbarello M;
    Int J Antimicrob Agents; 2018 Feb; 51(2):244-248. PubMed ID: 28842283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of and risk factors for carbapenem-resistant
    Barber KE; Wagner JL; Larry RC; Stover KR
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.